Compare semaglutide vs tirzepatide for weight loss, cost, effectiveness, and side effects. Find out which GLP-1 medication is right for you.
Quick takeaways
Introduction
If you're researching weight loss medications in 2026, you've likely come across two of the most talked-about options: semaglutide and tirzepatide. Both are powerful GLP-1-based treatments that can help people lose significant weight, but they work slightly differently and deliver different results.
In this guide, we break down semaglutide vs tirzepatide in terms of effectiveness, cost, side effects, and overall value so you can decide which one is right for your goals.
Semaglutide is a GLP-1 receptor agonist that helps regulate blood sugar, reduce appetite, and slow digestion. It's commonly prescribed for both type 2 diabetes and weight loss.
Popular brand-name versions include Ozempic and Wegovy. Semaglutide works by mimicking a natural hormone that signals fullness, helping users eat less and lose weight over time.
Tirzepatide is a newer medication that acts as a dual GIP and GLP-1 receptor agonist. This means it targets two hormones involved in blood sugar control and appetite regulation.
Sold under brand names like Mounjaro and Zepbound, tirzepatide has quickly gained attention for producing higher average weight loss compared to older GLP-1 medications.
The biggest difference between semaglutide and tirzepatide is how they work. Semaglutide targets only GLP-1 receptors, while tirzepatide targets both GLP-1 and GIP receptors, giving it a dual-action effect.
This dual mechanism is why tirzepatide often leads to more significant weight loss, but it can also come with slightly higher costs depending on the provider.
When comparing tirzepatide vs semaglutide for weight loss, tirzepatide consistently shows stronger results in clinical trials.
On average, semaglutide users lose around 10 to 15 percent of their body weight, while tirzepatide users can see weight loss closer to 15 to 22 percent, depending on dosage and adherence.
However, individual results vary based on lifestyle, dosage, and how your body responds to the medication.
Cost is one of the biggest deciding factors for most people. Semaglutide is generally more affordable, especially through telehealth providers and compounded options.
Tirzepatide tends to be more expensive due to higher demand and newer market entry, though pricing is becoming more competitive as more providers offer it.
If you're looking for the cheapest GLP-1 option, semaglutide is usually the better starting point.
Both medications have similar side effects, primarily related to digestion. Common issues include nausea, vomiting, diarrhea, and reduced appetite.
Tirzepatide may cause slightly stronger side effects in some users due to its dual-hormone action, but many people tolerate both medications well after the initial adjustment period.
If your primary goal is maximum weight loss and you can afford it, tirzepatide may be the better option due to its higher effectiveness.
If you're looking for a more budget-friendly option with proven results, semaglutide is still an excellent choice and widely used.
Ultimately, the best option depends on your budget, weight loss goals, and how your body responds to treatment.
Browse real-time pricing for semaglutide and tirzepatide from trusted providers.
Related articles
Compounded semaglutide can save you $700/month—but you need to understand what you're getting.
Same drug, different products—here's what actually separates Ozempic from Wegovy.
Phoenix NP has a layered pricing structure: a care-plan fee, separate medication pricing, and a narrower geographic audience than most national telehealth providers.
